A Case of TAFRO syndrome after COVID-19 vaccination
Hitomi Hirosea, Hitoshi Suzukia,c*, Yukako Umezawaa, Masako Iwasakia, Hiromitsu Fukudaa, Hisatsugu Takaharaa, Shigeki Tomitab, Yusuke Suzukic
a. Department of Nephrology, b. Department of Pathology, Juntendo University Urayasu Hospital, Chiba, Japan. c. Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Correspondence to:
Hitoshi Suzuki, M.D., Ph.D
Department of Nephrology, Juntendo University Urayasu Hospital
2-1-1 Tomioka, Urayasu-shi, Chiba 279-0021, Japan
Email: shitoshi@juntendo.ac.jp
Key words: COVID-19, mRNA vaccine, TAFRO syndrome, renal dysfunction